Back
Across Protocol (ACX) Logo

Across Protocol

ACX

#468
$0.04390
May 3, 2026USD
Signaling up for 12 days

About Across Protocol (ACX)

Across Protocol (ACX) is a cryptocurrency launched in 2021and operates on the Ethereum platform. Across Protocol has a current supply of 1,000,000,000 with 704,657,712.644535 in circulation. The last known price of Across Protocol is 0.04461602 USD and is up 1.31 over the last 24 hours. It is currently trading on 154 active market(s) with $1,609,144.28 traded over the last 24 hours. More information can be found at https://across.to/.

US Voters Remain Cautious About AI and Cryptocurre...

A recent public opinion poll in the US reveals that despite growing influence, Americans remain cautious about cryptocurrency investments and artificial intelligence development. The survey found that...

Nexo Analysis Reveals Increasing Bitcoin Accumulat...

A recent analysis by Nexo reveals that wallets holding more than 100 BTC are consistently increasing, indicating the return of 'smart money' to the Bitcoin market. According to data, these addresses h...

VanEck's HODL ETF Sees $2.1 Million Exit Amid Bitc...

A small outflow of $2.1 million from VanEck's HODL ETF has raised concerns about institutional investors' risk exposure to bitcoin, despite the asset's near-record price. The flow data suggests a caut...

Strategy

Choose a strategy for Across Protocol

Results

Analyze the results of your strategy. The table below shows all the trades that would have been made with your strategy.
Trade no.Entrance DateExit DateReturn %
1Jul 14, 2024Jul 25, 2024

-4.49%

2Aug 19, 2024Aug 26, 2024

-12.01%

3Oct 15, 2024Dec 9, 2024

234.75%

4Mar 23, 2025Mar 29, 2025

-17.00%

5Apr 29, 2025May 16, 2025

4.51%

6Jul 14, 2025Jul 31, 2025

3.91%

7Aug 12, 2025Aug 19, 2025

-13.38%

8Aug 25, 2025Aug 28, 2025

1.48%

9Jan 7, 2026Jan 22, 2026

-10.08%

10Mar 12, 2026Apr 15, 2026

-10.32%

11Apr 17, 2026N/A

-4.28%

All Time Strategy Return:

72.05%

All Time Price Return:

-87.08%

All returns are cumulative.